NASDAQ : NPCE
NeuroPace, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 13.01 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 446.56M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 422.19M |
| Enterprise Value | 440.42M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 34.32M |
| Shares Outstanding | 34.32M |
| Shares Change (YoY) | +8.60% |
| Shares Change (QoQ) | +1.15% |
| Owned by Insiders (%) | 4.10% |
| Owned by Institutions (%) | 73.76% |
| Float | 25.57M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.95 |
| Forward PS | 3.82 |
| PB Ratio | 35.49 |
| P/TBV Ratio | 35.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 4.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 4.94 |
| Quick Ratio | 3.82 |
| Debt / Equity | 5.88 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.92 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -103.27% |
| Return on Assets (ROA) | -7.47% |
| Return on Invested Capital (ROIC) | -8.78% |
| Return on Capital Employed (ROCE) | -15.26% |
| Weighted Average Cost of Capital (WACC) | 13.77% |
| Revenue Per Employee | $486,332 |
| Profits Per Employee | -$86,882 |
| Employee Count | 220 |
| Asset Turnover | 1.05 |
| Inventory Turnover | 1.40 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.93 |
| 52-Week Price Change | +21.42% |
| 50-Day Moving Average | 13.68 |
| 200-Day Moving Average | 14.98 |
| Relative Strength Index (RSI) | 39.29 |
| Average Volume (20 Days) | 100,678 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 886,230 |
| Short Previous Month | 903,626 |
| Short % of Shares Out | 2.58% |
| Short % of Float | 3.47% |
| Short Ratio (days to cover) | 6.96 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 106.99M |
| Gross Profit | 82.79M |
| Operating Income | -12.14M |
| Pretax Income | -16.17M |
| Net Income | -19.11M |
| EBITDA | -11.88M |
| EBIT | -12.14M |
| Loss Per Share | -$0.57 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 51.70M |
| Total Debt | 69.93M |
| Net Cash | -18.23M |
| Net Cash Per Share | -$0.53 |
| Equity (Book Value) | 11.88M |
| Book Value Per Share | 0.35 |
| Working Capital | 68.76M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -11.24M |
| Capital Expenditures | -369,000 |
| Depreciation & Amortization | 260,000 |
| Net Borrowing | -133,000 |
| Free Cash Flow | -11.61M |
| FCF Per Share | -$0.34 |
Margins
| Measure | Value |
|---|
| Gross Margin | 77.38% |
| Operating Margin | -11.34% |
| Pretax Margin | -15.12% |
| Profit Margin | -17.86% |
| EBITDA Margin | -11.10% |
| EBIT Margin | -11.34% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.60% |
| Shareholder Yield | -8.60% |
| Earnings Yield | -4.63% |
| FCF Yield | -2.75% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $20.00 |
| Price Target Difference | 62.60% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | 14.94% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -3.45 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |